Erenumab
NMCP.2020.0010
Phase 3 small_molecule terminated
Quick answer
Erenumab for Fibromyalgia is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Fibromyalgia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated